• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Results of a Randomized Clinical Trial of Aflibercept vs Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Is It Time to Retire Your Laser?

作者信息

Glassman Adam R

机构信息

Jaeb Center for Health Research, Tampa, Florida.

出版信息

JAMA Ophthalmol. 2017 Jul 1;135(7):685-686. doi: 10.1001/jamaophthalmol.2017.1652.

DOI:10.1001/jamaophthalmol.2017.1652
PMID:28570733
Abstract
摘要

相似文献

1
Results of a Randomized Clinical Trial of Aflibercept vs Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Is It Time to Retire Your Laser?阿柏西普对比全视网膜光凝治疗增殖性糖尿病视网膜病变的随机临床试验结果：是时候淘汰激光了吗？
JAMA Ophthalmol. 2017 Jul 1;135(7):685-686. doi: 10.1001/jamaophthalmol.2017.1652.
2
Cost Evaluation of Laser versus Intravitreal Aflibercept for Proliferative Diabetic Retinopathy.激光与玻璃体内注射阿柏西普治疗增殖性糖尿病视网膜病变的成本评估
Ophthalmology. 2018 Jul;125(7):1121-1122. doi: 10.1016/j.ophtha.2018.02.019. Epub 2018 Mar 20.
3
Interim Safety Data Comparing Ranibizumab With Panretinal Photocoagulation Among Participants With Proliferative Diabetic Retinopathy.比较增生性糖尿病视网膜病变患者中雷珠单抗与全视网膜光凝治疗的中期安全性数据。
JAMA Ophthalmol. 2017 Jun 1;135(6):672-673. doi: 10.1001/jamaophthalmol.2017.0969.
4
Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor.接受全视网膜光凝与玻璃体内抗血管内皮生长因子治疗后随访丢失的增生性糖尿病视网膜病变眼的结局。
Ophthalmology. 2019 Mar;126(3):407-413. doi: 10.1016/j.ophtha.2018.07.027. Epub 2018 Aug 2.
5
Infographic: Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation in patients with proliferative diabetic retinopathy (PDR): the CLARITY study.信息图：阿柏西普玻璃体内注射与全视网膜光凝治疗增殖性糖尿病视网膜病变（PDR）患者的临床疗效比较：CLARITY研究
Eye (Lond). 2024 Aug;38(Suppl 2):26-27. doi: 10.1038/s41433-023-02391-5. Epub 2023 Apr 21.
6
Intravitreal bevacizumab versus panretinal photocoagulation for treatment-naïve proliferative and severe nonproliferative diabetic retinopathy.玻璃体内注射贝伐单抗与全视网膜光凝治疗初治增殖性和重度非增殖性糖尿病视网膜病变的对比
Acta Ophthalmol. 2012 Nov;90(7):e573-4. doi: 10.1111/j.1755-3768.2011.02364.x. Epub 2012 Mar 9.
7
Comparison of the Efficacy Between Intravitreal Aflibercept and Laser Photocoagulation in the Treatment of Retinopathy of Prematurity.玻璃体内注射阿柏西普与激光光凝治疗早产儿视网膜病变的疗效比较
J Pediatr Ophthalmol Strabismus. 2020 Jan 1;57(1):54-60. doi: 10.3928/01913913-20191104-01.
8
CHOROIDAL THICKNESS CHANGES IN PROLIFERATIVE DIABETIC RETINOPATHY TREATED WITH PANRETINAL PHOTOCOAGULATION VERSUS PANRETINAL PHOTOCOAGULATION WITH INTRAVITREAL BEVACIZUMAB.全视网膜光凝联合玻璃体腔内注射贝伐单抗治疗增殖性糖尿病视网膜病变时脉络膜厚度的变化与单纯全视网膜光凝治疗的对比
Retina. 2016 Oct;36(10):1997-2005. doi: 10.1097/IAE.0000000000001027.
9
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial.阿柏西普与激光光凝及观察治疗对中心性浆液性脉络膜视网膜病变黄斑区累及及良好视力患者视力丧失影响的随机临床试验
JAMA. 2019 May 21;321(19):1880-1894. doi: 10.1001/jama.2019.5790.
10
How to manage patients with center-involving diabetic macular edema and good visual acuity? An answer to a common clinical question.如何管理患有累及黄斑中心凹的糖尿病性黄斑水肿且视力良好的患者？一个常见临床问题的答案。
Eye (Lond). 2019 Nov;33(11):1677-1678. doi: 10.1038/s41433-019-0567-z. Epub 2019 Aug 30.

引用本文的文献

1
Role of Oral Antioxidant Supplementation in the Current Management of Diabetic Retinopathy.口服抗氧化剂补充剂在糖尿病视网膜病变治疗中的作用。
Int J Mol Sci. 2021 Apr 13;22(8):4020. doi: 10.3390/ijms22084020.
2
Preclinical Efficacy and Safety of VEGF-Grab, a Novel Anti-VEGF Drug, and Its Comparison to Aflibercept.新型抗血管内皮生长因子药物 VEGF-Grab 的临床前疗效和安全性及其与阿柏西普的比较
Invest Ophthalmol Vis Sci. 2020 Nov 2;61(13):22. doi: 10.1167/iovs.61.13.22.
3
Long-term therapeutic effect in nonhuman primate eye from a single injection of anti-VEGF controlled release hydrogel.
单次注射抗血管内皮生长因子控释水凝胶对非人灵长类动物眼睛的长期治疗效果。
Bioeng Transl Med. 2019 Jun 10;4(2):e10128. doi: 10.1002/btm2.10128. eCollection 2019 May.
4
Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Factors Associated with Vision and Edema Outcomes.全视网膜光凝与雷珠单抗治疗增生型糖尿病视网膜病变：与视力和水肿结局相关的因素。
Ophthalmology. 2018 Nov;125(11):1776-1783. doi: 10.1016/j.ophtha.2018.04.039. Epub 2018 Jul 3.
5
Difference in the Vitreal Protein Profiles of Patients with Proliferative Diabetic Retinopathy with and without Intravitreal Conbercept Injection.接受玻璃体腔康柏西普注射与未接受该注射的增殖性糖尿病视网膜病变患者玻璃体蛋白质谱的差异
J Ophthalmol. 2018 Apr 19;2018:7397610. doi: 10.1155/2018/7397610. eCollection 2018.